CS
DXCM icon

Credit Suisse’s DexCom DXCM Stock Holding History

Credit Suisse’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-17,600
Closed -$378K – 4239
2015
Q3 		$378K Buy
+17,600
New +$393K ﹤0.01% 3595

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Credit Suisse's DXCM Position: Q1 2024 in Review

Credit Suisse reduced its DexCom (DXCM) stake by 2.2% in Q1 2024, selling an estimated $5.29M and leaving 1,916,217 shares worth $266M. The position accounts for 0.25% of the portfolio, ranked #67.

Credit Suisse first reported a position in DXCM in Q2 2013 and has held it in 44 quarters since. The position peaked at $549M in Q3 2021. 1,032 funds tracked by Wall St. Rank hold DXCM as of Q1 2024.

  • Credit Suisse held 1,916,217 shares of DexCom worth $266M as of Q1 2024.
  • Credit Suisse sold 42,104 DexCom shares in Q1 2024, an estimated $5.29M.
  • DexCom made up 0.25% of Credit Suisse's portfolio in Q1 2024, its #67 holding.
  • Credit Suisse first reported a position in DexCom in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's DexCom position peaked at $549M in Q3 2021.
  • 1,032 funds tracked by Wall St. Rank held DexCom as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.